A detailed history of Massachusetts Wealth Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Massachusetts Wealth Management holds 3,150 shares of NVO stock, worth $276,097. This represents 0.24% of its overall portfolio holdings.

Number of Shares
3,150
Previous 3,175 0.79%
Holding current value
$276,097
Previous $453 Million 17.24%
% of portfolio
0.24%
Previous 0.3%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$119.07 - $145.42 $2,976 - $3,635
-25 Reduced 0.79%
3,150 $375 Million
Q1 2024

Apr 19, 2024

BUY
$102.11 - $135.92 $51,055 - $67,960
500 Added 18.69%
3,175 $408 Million
Q4 2023

Jan 24, 2024

BUY
$87.78 - $105.45 $234,811 - $282,078
2,675 New
2,675 $277 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Massachusetts Wealth Management Portfolio

Follow Massachusetts Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Wealth Management with notifications on news.